在中国的瘤学家中,人工智能知识,态度,感知和愿意使用人工智能:全国性的横截面研究
Xiaomin Xiong1,2, Mingming Xiao3, Haixia Liu4
1School of Medicine, Chongqing University, Chongqing, China.
BMC medical education
|March 13, 2026
概括
中国的瘤学家表现出强烈的AI接受和使用AI产品的意愿,与高级头和AI经验相关的意愿更高. 针对性教育是人工智能在瘤学中整合的关键.
科学领域:
- 在瘤学瘤学.
- 医疗保健中的人工智能
- 医疗信息学 医疗信息学
背景情况:
- 人工智能在中国瘤学环境中的整合正在增长.
- 了解瘤学家的观点对于有效实施人工智能至关重要.
- 这项研究评估了中国瘤学家的AI知识,态度和使用意图.
研究的目的:
- 评估中国全国瘤学家的AI知识,态度,感知和意愿.
- 确定影响瘤学家在实践中采用AI意愿的因素.
主要方法:
- 在中国31个地区的1538名瘤学家中进行了横截面调查.
- 在2023年8月至11月期间,进行了22项在线问卷调查.
- 数据通过温在线平台收集,并通过中国抗癌协会分发.
主要成果:
- 达到了87.78% (1350名受访者) 的高完成率.
- 90%的瘤学家使用了医疗人工智能,14.59%使用了ChatGPT.
- 观察到积极的态度和高意愿 (平均得分4.162/5) 使用人工智能,受到高级头和人工智能经验等因素的影响.
结论:
- 中国的瘤学家表现出积极的态度和对使用人工智能的强烈意愿,尽管人们担心人工智能会取代医生.
- 高级瘤学家和具有更大的AI知识/经验的人士表现出更高的意愿.
- 针对性的人工智能教育和增加暴露是成功在中国瘤学中整合人工智能的建议.
相关概念视频
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
Issues And Trends In Healthcare Delivery System
6.3K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.3K
Cancer Survival Analysis
811
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
811
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
